Home » Analyst Articles – US
Bank of America Begins Coverage on Payoneer Global (NASDAQ:PAYO)
Stock analysts at Bank of America assumed coverage on shares of Payoneer Global (NASDAQ:PAYO – Get Free Report) in a research note issued on Wednesday, Marketbeat.com reports. The firm set a “buy” rating and a $6.00... More of this article »
Cantor Fitzgerald Issues Pessimistic Forecast for Zillow Group (NASDAQ:ZG) Stock Price
Zillow Group (NASDAQ:ZG – Get Free Report) had its price target dropped by investment analysts at Cantor Fitzgerald from $56.00 to $46.00 in a research note issued on Wednesday,Benzinga reports. The firm currently has a “neutral”... More of this article »
Barclays Boosts Privia Health Group (NASDAQ:PRVA) Price Target to $25.00
Privia Health Group (NASDAQ:PRVA – Get Free Report) had its price objective upped by stock analysts at Barclays from $23.00 to $25.00 in a report released on Wednesday,Benzinga reports. The firm presently has an “equal... More of this article »
Zillow Group (NASDAQ:ZG) Earns “Outperform” Rating from Royal Bank Of Canada
Zillow Group (NASDAQ:ZG – Get Free Report)‘s stock had its “outperform” rating reaffirmed by Royal Bank Of Canada in a research report issued on Wednesday,Benzinga reports. They presently have a $95.00 price... More of this article »
Strata Critical Medical (NASDAQ:SRTA) Coverage Initiated at B. Riley Financial
Equities research analysts at B. Riley Financial initiated coverage on shares of Strata Critical Medical (NASDAQ:SRTA – Get Free Report) in a note issued to investors on Wednesday, Marketbeat Ratings reports. The firm set a “buy”... More of this article »
Strata Critical Medical (NASDAQ:SRTA) Coverage Initiated at Craig Hallum
Research analysts at Craig Hallum initiated coverage on shares of Strata Critical Medical (NASDAQ:SRTA – Get Free Report) in a research note issued to investors on Wednesday, MarketBeat.com reports. The brokerage set a “buy”... More of this article »
BTIG Research Reiterates “Buy” Rating for Spectral AI (NASDAQ:MDAI)
Spectral AI (NASDAQ:MDAI – Get Free Report)‘s stock had its “buy” rating reissued by analysts at BTIG Research in a research note issued to investors on Wednesday,Benzinga reports. They presently have a $3.00... More of this article »
Bank of America Issues Pessimistic Forecast for LENZ Therapeutics (NASDAQ:LENZ) Stock Price
LENZ Therapeutics (NASDAQ:LENZ – Get Free Report) had its price target dropped by Bank of America from $35.00 to $29.00 in a note issued to investors on Wednesday,Benzinga reports. The firm presently has a “buy”... More of this article »
Truist Financial Upgrades Sutro Biopharma (NASDAQ:STRO) to Strong-Buy
Sutro Biopharma (NASDAQ:STRO – Get Free Report) was upgraded by equities researchers at Truist Financial to a “strong-buy” rating in a note issued to investors on Wednesday,Zacks.com reports. A number of other analysts... More of this article »
Rapport Therapeutics (NASDAQ:RAPP) Raised to “Strong-Buy” at Truist Financial
Rapport Therapeutics (NASDAQ:RAPP – Get Free Report) was upgraded by research analysts at Truist Financial to a “strong-buy” rating in a report released on Wednesday,Zacks.com reports. RAPP has been the topic of several... More of this article »
Solid Biosciences (NASDAQ:SLDB) Stock Rating Upgraded by Truist Financial
Solid Biosciences (NASDAQ:SLDB – Get Free Report) was upgraded by stock analysts at Truist Financial to a “strong-buy” rating in a report released on Wednesday,Zacks.com reports. Other equities analysts have also... More of this article »
HC Wainwright Reaffirms Neutral Rating for Phunware (NASDAQ:PHUN)
Phunware (NASDAQ:PHUN – Get Free Report)‘s stock had its “neutral” rating reissued by research analysts at HC Wainwright in a research report issued to clients and investors on Wednesday,Benzinga reports. They... More of this article »
Rothschild & Co Redburn Reaffirms “Neutral” Rating for Mondelez International (NASDAQ:MDLZ)
Mondelez International (NASDAQ:MDLZ – Get Free Report)‘s stock had its “neutral” rating reaffirmed by Rothschild & Co Redburn in a research report issued to clients and investors on Wednesday, Marketbeat... More of this article »
HC Wainwright Forecasts Strong Price Appreciation for Ocugen (NASDAQ:OCGN) Stock
Ocugen (NASDAQ:OCGN – Get Free Report) had its price target upped by investment analysts at HC Wainwright from $7.00 to $10.00 in a note issued to investors on Wednesday,Benzinga reports. The brokerage presently has a “buy”... More of this article »
Stephens Initiates Coverage on Mercantile Bank (NASDAQ:MBWM)
Stephens started coverage on shares of Mercantile Bank (NASDAQ:MBWM – Get Free Report) in a report released on Wednesday, MarketBeat reports. The firm set an “equal weight” rating and a $54.00 price target on the... More of this article »
Wedbush Upgrades Rezolute (NASDAQ:RZLT) to “Outperform”
Rezolute (NASDAQ:RZLT – Get Free Report) was upgraded by equities researchers at Wedbush from a “neutral” rating to an “outperform” rating in a report released on Wednesday, MarketBeat.com reports. The... More of this article »
PTC Therapeutics (NASDAQ:PTCT) Raised to “Strong-Buy” at Truist Financial
PTC Therapeutics (NASDAQ:PTCT – Get Free Report) was upgraded by Truist Financial to a “strong-buy” rating in a research report issued to clients and investors on Wednesday,Zacks.com reports. Other equities research... More of this article »
Autolus Therapeutics (NASDAQ:AUTL) Raised to Strong-Buy at Truist Financial
Autolus Therapeutics (NASDAQ:AUTL – Get Free Report) was upgraded by investment analysts at Truist Financial to a “strong-buy” rating in a note issued to investors on Wednesday,Zacks.com reports. Other equities research... More of this article »
Truist Financial Upgrades Jazz Pharmaceuticals (NASDAQ:JAZZ) to “Strong-Buy”
Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) was upgraded by investment analysts at Truist Financial to a “strong-buy” rating in a note issued to investors on Wednesday,Zacks.com reports. JAZZ has been the... More of this article »
Caribou Biosciences (NASDAQ:CRBU) Raised to “Strong-Buy” at Truist Financial
Caribou Biosciences (NASDAQ:CRBU – Get Free Report) was upgraded by equities researchers at Truist Financial to a “strong-buy” rating in a report released on Wednesday,Zacks.com reports. Separately, Weiss Ratings... More of this article »
Praxis Precision Medicines (NASDAQ:PRAX) Raised to “Strong-Buy” at Truist Financial
Praxis Precision Medicines (NASDAQ:PRAX – Get Free Report) was upgraded by research analysts at Truist Financial to a “strong-buy” rating in a report issued on Wednesday,Zacks.com reports. Several other equities research... More of this article »
KalVista Pharmaceuticals (NASDAQ:KALV) Stock Price Expected to Rise, Needham & Company LLC Analyst Says
KalVista Pharmaceuticals (NASDAQ:KALV – Get Free Report) had its price target lifted by stock analysts at Needham & Company LLC from $35.00 to $36.00 in a research note issued to investors on Wednesday,Benzinga reports.... More of this article »
CRISPR Therapeutics (NASDAQ:CRSP) Raised to Strong-Buy at Truist Financial
CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) was upgraded by stock analysts at Truist Financial to a “strong-buy” rating in a research report issued on Wednesday,Zacks.com reports. A number of other equities... More of this article »
Truist Financial Upgrades BioMarin Pharmaceutical (NASDAQ:BMRN) to “Strong-Buy”
BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report) was upgraded by equities researchers at Truist Financial to a “strong-buy” rating in a report issued on Wednesday,Zacks.com reports. Other research analysts... More of this article »
Truist Financial Upgrades Axsome Therapeutics (NASDAQ:AXSM) to Strong-Buy
Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) was upgraded by Truist Financial to a “strong-buy” rating in a note issued to investors on Wednesday,Zacks.com reports. Several other equities research analysts... More of this article »
Truist Financial Upgrades Larimar Therapeutics (NASDAQ:LRMR) to Strong-Buy
Larimar Therapeutics (NASDAQ:LRMR – Get Free Report) was upgraded by investment analysts at Truist Financial to a “strong-buy” rating in a research report issued to clients and investors on Wednesday,Zacks.com reports. Several... More of this article »
Truist Financial Upgrades ArriVent BioPharma (NASDAQ:AVBP) to “Strong-Buy”
ArriVent BioPharma (NASDAQ:AVBP – Get Free Report) was upgraded by equities researchers at Truist Financial to a “strong-buy” rating in a report released on Wednesday,Zacks.com reports. AVBP has been the topic of... More of this article »
Genmab A/S (NASDAQ:GMAB) Raised to “Strong-Buy” at Truist Financial
Genmab A/S (NASDAQ:GMAB – Get Free Report) was upgraded by stock analysts at Truist Financial to a “strong-buy” rating in a note issued to investors on Wednesday,Zacks.com reports. A number of other brokerages have... More of this article »
Canadian Imperial Bank of Commerce Upgrades Dollarama (OTCMKTS:DLMAF) to Strong-Buy
Dollarama (OTCMKTS:DLMAF – Get Free Report) was upgraded by research analysts at Canadian Imperial Bank of Commerce to a “strong-buy” rating in a research note issued to investors on Wednesday,Zacks.com reports. A... More of this article »
Dollarama (OTCMKTS:DLMAF) Stock Rating Upgraded by National Bank Financial
Dollarama (OTCMKTS:DLMAF – Get Free Report) was upgraded by equities researchers at National Bank Financial to a “strong-buy” rating in a note issued to investors on Wednesday,Zacks.com reports. A number of other... More of this article »
Truist Financial Upgrades BioNTech (NASDAQ:BNTX) to “Strong-Buy”
BioNTech (NASDAQ:BNTX – Get Free Report) was upgraded by Truist Financial to a “strong-buy” rating in a research report issued on Wednesday,Zacks.com reports. A number of other equities analysts also recently commented... More of this article »
Dollarama (OTCMKTS:DLMAF) Raised to Strong-Buy at TD Securities
Dollarama (OTCMKTS:DLMAF – Get Free Report) was upgraded by research analysts at TD Securities to a “strong-buy” rating in a report issued on Wednesday,Zacks.com reports. Other equities research analysts have also... More of this article »
Catalyst Pharmaceuticals (NASDAQ:CPRX) Stock Rating Upgraded by Truist Financial
Catalyst Pharmaceuticals (NASDAQ:CPRX – Get Free Report) was upgraded by equities research analysts at Truist Financial to a “strong-buy” rating in a research note issued on Wednesday,Zacks.com reports. Several other... More of this article »
Iovance Biotherapeutics (NASDAQ:IOVA) Stock Rating Upgraded by Truist Financial
Iovance Biotherapeutics (NASDAQ:IOVA – Get Free Report) was upgraded by equities research analysts at Truist Financial to a “hold” rating in a research note issued to investors on Wednesday,Zacks.com reports. A number... More of this article »
Summit Therapeutics (NASDAQ:SMMT) Raised to Strong-Buy at Truist Financial
Summit Therapeutics (NASDAQ:SMMT – Get Free Report) was upgraded by investment analysts at Truist Financial to a “strong-buy” rating in a report released on Wednesday,Zacks.com reports. Other equities research analysts... More of this article »
Arcus Biosciences (NYSE:RCUS) Stock Rating Upgraded by Truist Financial
Arcus Biosciences (NYSE:RCUS – Get Free Report) was upgraded by research analysts at Truist Financial to a “strong-buy” rating in a report released on Wednesday,Zacks.com reports. Other equities analysts have also... More of this article »
Truist Financial Upgrades Compugen (NASDAQ:CGEN) to “Strong-Buy”
Compugen (NASDAQ:CGEN – Get Free Report) was upgraded by equities researchers at Truist Financial to a “strong-buy” rating in a research report issued to clients and investors on Wednesday,Zacks.com reports. Other... More of this article »
Truist Financial Upgrades WAVE Life Sciences (NASDAQ:WVE) to Strong-Buy
WAVE Life Sciences (NASDAQ:WVE – Get Free Report) was upgraded by stock analysts at Truist Financial to a “strong-buy” rating in a research note issued to investors on Wednesday,Zacks.com reports. WVE has been the... More of this article »
Truist Financial Upgrades Ultragenyx Pharmaceutical (NASDAQ:RARE) to Strong-Buy
Ultragenyx Pharmaceutical (NASDAQ:RARE – Get Free Report) was upgraded by analysts at Truist Financial to a “strong-buy” rating in a research report issued to clients and investors on Wednesday,Zacks.com reports. Several... More of this article »
Intellia Therapeutics (NASDAQ:NTLA) Stock Rating Upgraded by Truist Financial
Intellia Therapeutics (NASDAQ:NTLA – Get Free Report) was upgraded by equities research analysts at Truist Financial to a “strong-buy” rating in a research report issued to clients and investors on Wednesday,Zacks.com... More of this article »
Jefferies Financial Group Upgrades Dollarama (OTCMKTS:DLMAF) to “Strong-Buy”
Dollarama (OTCMKTS:DLMAF – Get Free Report) was upgraded by analysts at Jefferies Financial Group to a “strong-buy” rating in a research note issued on Wednesday,Zacks.com reports. Several other brokerages have also... More of this article »
Exelixis (NASDAQ:EXEL) Raised to Strong-Buy at Truist Financial
Exelixis (NASDAQ:EXEL – Get Free Report) was upgraded by investment analysts at Truist Financial to a “strong-buy” rating in a research note issued on Wednesday,Zacks.com reports. Several other research firms have... More of this article »
Revolution Medicines (NASDAQ:RVMD) Stock Rating Upgraded by Truist Financial
Revolution Medicines (NASDAQ:RVMD – Get Free Report) was upgraded by analysts at Truist Financial to a “strong-buy” rating in a research note issued on Wednesday,Zacks.com reports. Several other equities research... More of this article »
Truist Financial Upgrades Corcept Therapeutics (NASDAQ:CORT) to Strong-Buy
Corcept Therapeutics (NASDAQ:CORT – Get Free Report) was upgraded by research analysts at Truist Financial to a “strong-buy” rating in a research report issued on Wednesday,Zacks.com reports. CORT has been the topic... More of this article »
Truist Financial Upgrades Taysha Gene Therapies (NASDAQ:TSHA) to Strong-Buy
Taysha Gene Therapies (NASDAQ:TSHA – Get Free Report) was upgraded by Truist Financial to a “strong-buy” rating in a research report issued to clients and investors on Wednesday,Zacks.com reports. Several other research... More of this article »
Vertex Pharmaceuticals (NASDAQ:VRTX) Stock Rating Upgraded by Truist Financial
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) was upgraded by investment analysts at Truist Financial to a “strong-buy” rating in a report issued on Wednesday,Zacks.com reports. VRTX has been the topic of... More of this article »
Voyager Therapeutics (NASDAQ:VYGR) Stock Rating Upgraded by Truist Financial
Voyager Therapeutics (NASDAQ:VYGR – Get Free Report) was upgraded by Truist Financial to a “strong-buy” rating in a note issued to investors on Wednesday,Zacks.com reports. VYGR has been the topic of a number of other... More of this article »
BTIG Research Boosts Denali Therapeutics (NASDAQ:DNLI) Price Target to $38.00
Denali Therapeutics (NASDAQ:DNLI – Get Free Report) had its target price lifted by equities researchers at BTIG Research from $36.00 to $38.00 in a report issued on Wednesday,Benzinga reports. The brokerage presently has a “buy”... More of this article »